Mark A. Schembri mainly investigates Microbiology, Escherichia coli, Virulence, Bacterial adhesin and Fimbria. His Microbiology study combines topics from a wide range of disciplines, such as Bacteriuria, Urinary system and Biofilm. His Escherichia coli research includes themes of Phenotype, Multiple drug resistance, Peptide sequence and Bacteria.
His Virulence research is multidisciplinary, incorporating elements of Oxidase test, Innate immune system and Function. His biological study spans a wide range of topics, including Bacterial genetics, Molecular biology, Phase variation and Cell biology. His Fimbria study incorporates themes from Plasmid, Pilus and Effector.
His primary areas of investigation include Escherichia coli, Microbiology, Virulence, Bacterial adhesin and Gene. Mark A. Schembri regularly links together related areas like Bacteria in his Escherichia coli studies. Mark A. Schembri works mostly in the field of Microbiology, limiting it down to topics relating to Biofilm and, in certain cases, Cell aggregation.
Virulence and Bacteriuria are frequently intertwined in his study. His research integrates issues of Bacterial genetics, Phenotype, Recombinant DNA and Cell biology in his study of Bacterial adhesin. Mark A. Schembri interconnects Virulence factor, Gene cluster and Pilus in the investigation of issues within Fimbria.
Mark A. Schembri mainly focuses on Escherichia coli, Microbiology, Virulence, Gene and Genetics. Mark A. Schembri works in the field of Escherichia coli, focusing on Fimbria in particular. His work is dedicated to discovering how Fimbria, Heterologous expression are connected with Glycan, Glycomics and Fast protein liquid chromatography and other disciplines.
The various areas that Mark A. Schembri examines in his Microbiology study include Innate immune system and Clone. The concepts of his Virulence study are interwoven with issues in INFECTION URINARY TRACT, Translational research, Pathophysiology and Tuberculosis. His work on Plasmid, Whole genome sequencing, Genome and Mobile genetic elements as part of general Genetics study is frequently linked to Context, therefore connecting diverse disciplines of science.
Mark A. Schembri mostly deals with Microbiology, Escherichia coli, Innate immune system, Antibiotic resistance and Drug resistance. His Microbiology research incorporates elements of Gene and Transposable element. His Escherichia coli study combines topics in areas such as Complementation, Mutant, Transposon mutagenesis, Cephalosporin and Clone.
His studies in Clone integrate themes in fields like Probiotic, Fimbria and Colonization. His Innate immune system study deals with Macrophage intersecting with Bacteria, Pathogen, Regulation of gene expression and Hemolysin. In his study, which falls under the umbrella issue of Antibiotic resistance, Lineage, Whole genome sequencing and MCR-1 is strongly linked to Plasmid.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors
Morten Hentzer;Hong Wu;Jens Bo Andersen;Kathrin Riedel.
The EMBO Journal (2003)
Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract
I Connell;W Agace;P Klemm;M Schembri.
Proceedings of the National Academy of Sciences of the United States of America (1996)
Global gene expression in Escherichia coli biofilms
Mark A Schembri;Kristian Kjaergaard;Per Klemm.
Molecular Microbiology (2003)
Global dissemination of a multidrug resistant Escherichia coli clone
Nicola K. Petty;Nouri L. Ben Zakour;Mitchell Stanton-Cook;Elizabeth Skippington.
Proceedings of the National Academy of Sciences of the United States of America (2014)
Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin
Julie Bouckaert;Jenny Berglund;Mark Schembri;Erwin De Genst.
Molecular Microbiology (2004)
Development and maturation of Escherichia coli K-12 biofilms.
Andreas Reisner;Janus A. J. Haagensen;Mark A. Schembri;Ellen L. Zechner.
Molecular Microbiology (2003)
Bacterial adhesins: function and structure.
Per Klemm;Mark A. Schembri.
International Journal of Medical Microbiology (2000)
Pathogenic adaptation of Escherichia coli by natural variation of the FimH adhesin
Evgeni V. Sokurenko;Veronika Chesnokova;Daniel E. Dykhuizen;Itzhak Ofek.
Proceedings of the National Academy of Sciences of the United States of America (1998)
Host–pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection
Thomas J. Hannan;Makrina Totsika;Kylie J. Mansfield;Kate H. Moore.
Fems Microbiology Reviews (2012)
The emerging threat of multidrug-resistant Gram-negative bacteria in urology
Hosam M. Zowawi;Patrick N. A. Harris;Matthew J. Roberts;Paul A. Tambyah.
Nature Reviews Urology (2015)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Queensland
Griffith University
Technical University of Denmark
University of Queensland
University of Queensland
University of Queensland
University of Malaya
Université Paris Cité
Institut Pasteur
Griffith University
University of Montreal
Inter-American Development Bank
Tsinghua University
Technical University of Denmark
Sichuan University
National Institute of Polar Research
University of Adelaide
Spanish National Research Council
University College London
Nexstim (Finland)
University of Florida
University of Rochester
The University of Texas MD Anderson Cancer Center
Michigan State University
Nationwide Children's Hospital
Stanford University